Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TAK | TMO |
|---|---|---|
| Price | $18.58 | $672.85 |
| Change today | ▼ 1.22% | ▲ 1.13% |
| Market cap | $59.34B | $248.78B |
| Return, 3 months | +18.2% | +36.7% |
| Return, year to date | +21.2% | +16.4% |
| Return, 1 year | +29.2% | +44.2% |
| P/E (TTM) | -56.3 | 36.2 |
| P/B | 1.2 | 4.7 |
| P/E percentile vs own 5y | 3rd | 63rd |
| Dividend yield | 3.22% | 0.27% |
| Revenue growth (YoY, latest qtr) | +10.2% | +10.5% |
| Net profit growth (YoY) | -8.9% | +7.6% |
| Gross margin | 65.5% | 40.8% |
| Operating margin | 10.4% | 18.3% |
| Net margin | -3.5% | 15.0% |
| Return on equity | -2.3% | 13.5% |
| Analyst target vs. price | +138.3% | -4.9% |
| Analyst buy share | 100% | 83% |
| RSI (14) | 64 | 69 |
| 30-day volatility | 18.8% | 24.7% |
| Max drawdown, 1 year | -19.9% | -31.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.